[Novel coronavirus infection COVID-19: extrapulmonary manifestations].
Igor MaevAlexander ShpektorE Y VasilievaV N ManchurovDmitrii N AndreevPublished in: Terapevticheskii arkhiv (2020)
The novel coronavirus infection COVID-19 in most cases manifests with respiratory symptoms and fever, however, some patients may have cardiovascular and gastroenterological manifestations. A feature of the clinical syndrome of COVID-19 is the development of pronounced immunopathological reactions and disorders of hemostasis, leading to the development of a wide range of cardiovascular complications. The course of COVID-19 may be complicated by the development of acute myocardial infarction, venous and arterial thrombosis and thromboembolism in various vascular pools, the development of acute myocardial damage and myocarditis. Among the gastroenterological manifestations, diarrhea, nausea or vomiting, as well as abdominal pain, are most often detected. These symptoms may precede the appearance of respiratory signs of the disease, and in some cases come to the fore in the clinical picture of the disease. In addition, in some patients there are laboratory signs of liver injury (increased serum transaminases). The exact pathogenesis of the above disorders continues to be studied.
Keyphrases
- coronavirus disease
- sars cov
- liver injury
- end stage renal disease
- drug induced
- acute myocardial infarction
- ejection fraction
- newly diagnosed
- chronic kidney disease
- abdominal pain
- respiratory syndrome coronavirus
- left ventricular
- machine learning
- liver failure
- physical activity
- depressive symptoms
- heart failure
- pulmonary embolism
- oxidative stress
- patient reported outcomes
- atrial fibrillation
- sleep quality
- hepatitis b virus
- patient reported
- case report
- molecular dynamics
- solid state